Abstract
Alzheimer’s disease is a degenerative brain disease first described by the German psychiatrist Alois Alzheimer (Alzheimer, 1907). His initial report was based upon the histological examination of brain tissue from a 51 year old female patient who experienced a rapid progressive deterioration of memory and died four and a half years after the onset of the first symptoms with total loss of mental functions. The brain of this woman showed generalized atrophy without macroscopic lesions. Using a novel silver staining method developed by Bielschowsky, Alzheimer found that more than a quarter of the cortical neurons contained fibrillary tangles, and that this abnormality was accompanied by the extracellular deposition of “multiple miliary lesions”, containing a “unique substance” which was later recognized to be amyloid. In his initial report, Alzheimer also described severe loss of nerve cells, which was most prominent in the upper layers of the brain cortex. More recently, Terry and colleagues used computerized image processing to confirm the loss of cortical neurons, and showed that large cortical neurons are particularly affected (Terry et al., 1981). Neuronal atrophy and the presence of degenerating neurites in the immediate vicinity of amyloid plaques has generated two controversial hypotheses: First, that amyloid is toxic to neurons, and, second, that amyloid is a byproduct of neuronal atrophy formed by neurons during their degeneration.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson JP, Esch FS, Keim PS, Sambamurti K, Lieberburg I and Robakis NK (1991) Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells. Neurosci Lett 128:126–128
Alzheimer A (1907) Ueber eine eigenartige Erkrankung der Hirnrinde. Allg Z Psych & Psych-Gerichtl Med 64:146–148.
Berridge MJ and Irvine RF (1989) Inositol phosphates and cell signalling. Nature 341:197–204
Barany M, Chang Y-C and Arus C (1985) Increased glycerol-3-phosphoryl-choline in post-mortem Alzheimer’s brain. Lancet i:517
Baskin F, Rosenberg RN and Greenberg BD (1991) Increased release of an amyloidogenic C-terminal Alzheimer amyloid precursor protein fragment from stressed PC-12 cells. J Neurosci Res 29:127–132
Blusztajn JK, Lopez Gonzalez-Coviella I, Logue M, Growdon JH and Wurtman RJ (1990) Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer’s disease but not of Down’s syndrome patients. Brain Res 536:240–244
Blusztajn JK and Wurtman RJ (1983) Choline and cholinergic neurons. Science 221:614–620
Buxbaum JD, Gandy SE, Cicchetti P, Ehrlich ME, Czernik AJ, Fracasso RP, Ramabhadran TV, Unterbeck AJ and Greengard P (1990) Processing of Alzheimer beta/A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci USA 87:6003–6006
Cole G, Dobkins KR, Hansen LA, Terry RD and Saitoh T (1988) Decreased levels of protein kinase C in Alzheimer brain. Brain Res 452:165–174
Dyrks T, Weidemann A, Multhaup G, Salbaum JM, Lemaire H-G, Kang L, Mueller-Hill B, Masters CL and Beyreuther K (1988) Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer’s disease. EMB0 J 7:949–957
Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D and Ward P (1990) Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248:1122–1124
Estus S, Golde TE, Kunishita T, Blades D, Lowery D, Eisen M, Usiak M, Qu X, Tabira T, Greenberg BD and Younkin SG (1992) Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 255:726–728.
Exton JH (1990) Signaling through phosphatidylcholine breakdown. J Biol Chem 265:1–4
Farooqui AA, Liss L and Horrocks L (1988) Stimulation of lipolytic enzymes in Alzheimer’s disease. Ann Neurol 23:306–308
Glenner GG and Wong CW (1984) Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885–890
Gandy S, Czernik AJ and Greengard P (1988) Phosphorylation of Alzheimer’s disease amyloid precursor peptide by protein kinase C and Ca2+/ calmodulin-dependent protein kinase II. Proc Natl Acad Sci USA 85:6218–6221
Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M and Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349:704–706
Golde TE, Estus S, Younkin LH, Selkoe DJ and Younkin SG (1992) Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255:728–730.
Goldgaber D, Lerman M, McBride OW, Saffiotti U and Gajdusek DC (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s disease. Science 235:877–880
Henriksson T, Barbour RM, Braa S, Ward P, Fritz LC, Johnson-Wood K, Chung HD, Burke W, Reinikainen KJ, Riekkinen P and Schenk DB (1991) Analysis and quantitation of the beta-amyloid precursor protein in the cerebrospinal fluid of Alzheimer’s disease patients with a monoclonal antibody-base immunoassay. J Neurochem 56:1037–1042
Ishiura S (1991) Proteolytic cleavage of the Alzheimer’s disease amyloid A4 precursor protein. J Neurochem 56:363–369
Kanfer JN and McCartney DG (1989) Glycerophosphorylcholine phosphodiesterase activity of rat brain myelin. J Neurosci Res 24:231–240
Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H, Multhaup G, Beyreuther K and Mueller-Hill B (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell surface receptor. Nature 325:733–736
Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S and Ito H (1988) Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity. Nature 331:530–532
Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL and Beyreuther K (1985) Amyloid plaque core protein in Alzheimer’s disease and Down’s syndrome. Proc Natl Acad Sci USA 82:4245–4249
Miatto O, Gonzalez G, Buonanno F and Growdon JH (1986) In vitro 31P NMR spectroscopy detects altered phospholipid metabolism in Alzheimer’s disease. Can J Neurol Sci 13:535–539
Nishizuka Y (1986) Studies and perspectives of protein kinase C. Science 233:305–312
Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH and Wurtman RJ (1992) Evidence for a membrane defect in Alzheimer’s disease brain. Proc Natl Acad Sci USA 89:1671–1675
Olson MI and Shaw C-M (1969) Presenile dementia and Alzheimer’s disease in mongolism. Brain 92:147–156
Oltersdorf T, Ward PJ, Henricksson T, Beattie EC, Neve R, Lieberburg I and Fritz LC (1990) The Alzheimer amyloid precursor protein. J Biol Chem 265:4492–4497
Palmert MA, Berman Podlisny M, Witker DS, Oltersdorf T, Younkin LH, Selkoe DJ and Younkin SG (1989) The beta-amyloid protein precursor of Alzheimer’s disease has soluble derivatives found in human brain and cerebrospinal fluid. Proc Natl Acad Sci USA 86:6338–6342
Pettegrew JW, Panchalingam K, Moosy J, Martinez J, Rao G and Boiler F (1988) Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer’s disease. Arch Neurol 45:1093–1096
Pettegrew JW, Kopp SJ, Minshew NJ, Glonek T, Feliksik JM, Tow JP and Cohen MM (1987) 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: Preliminary observations. J Neuropathol Exp Neurol 46:419–430
Podlisny MB, Lee G and Selkoe DJ (1987) Gene dosage of the amyloid-beta precursor protein in Alzheimer’s disease. Science 238:669–671
Prior R, Moenning U, Schreiter-Gasser U, Weidemann A, Blennow K, Gottfries CG, Masters CL and Beyreuther K (1991) Quantitative changes in the amyloid beta/A4 precursor protein in Alzheimer cerebrospinal fluid. Neurosci Lett 124:69–73
St. George-Hyslop PH, Tanzi RE, Polinsky RJ, Neve RL, Pollen D (1987) absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer’s disease. Science 235:885–889
Selkoe D (1990) Deciphering Alzheimer’s disease: The amyloid precursor protein yields clues. Science 248:1058–1060
Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL (1990) Evidence that beta-amyloid protein in Alzheimer’s disease in not derived by normal processing. Science 248:492–495
Stokes CE, Hawthorne JN (1987) Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains. J Neurochem 48:1018–1021
Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F, Cordell B (1988) A new A4 amyloid mRNA contains a domain homologous to serine protease inhibitors. Nature 331:525–527
Tanzi RE, Bird ED, Latt SA, Neve RL (1987) The amyloid beta protein gene is not duplicated in brains from patients with Alzheimer’s disease. Science 238:666–669
Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, Neve RL (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA assaciated with Alzheimer’s disease. Nature 331:528–530
Terry RD, Peck A, DeTeresa R, Schechter R, Horoupian DS (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 10:184–192
Wang R, Meschia JF, Cotter RJ, Sisodia SS (1991) Secretion of the beta/A4 amyloid precursor protein. Identification of a cleavage site in cultured mammalian cells. J Biol Chem 266:16960–16964
Weidemann A, Koenig G, Bunke D, Fischer P, Salbaum JM, Masters CL and Beyreuther K (1989) Identification, biogenesis, and localization of precursors of Alzheimer’s disease A4 amyloid protein. Cell 57:115–126.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Nitsch, R.M., Slack, B.E., Growdon, J.H., Wurtman, R.J. (1993). Accelerated Cell Membrane Degradation in Alzheimer’s Disease Brain: Relationship to Amyloid Formation?. In: Massarelli, R., Horrocks, L.A., Kanfer, J.N., Löffelholz, K. (eds) Phospholipids and Signal Transmission. Nato ASI Series, vol 70. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-02922-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-662-02922-0_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-02924-4
Online ISBN: 978-3-662-02922-0
eBook Packages: Springer Book Archive